MyAverix Finance
AS · Healthcare
Pharming Group NV (PHARM)
Biotechnology
Pharming Group NV (PHARM) is listed on AS in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $789.59M, P/E ratio is 55.90, net margin is 3.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PHARM
Pharming Group NV (PHARM) — FAQ
What is Pharming Group NV's market cap?
Pharming Group NV (PHARM) has a reported market cap of $789.59M (data as of 2026-05-24).
What is PHARM's P/E ratio?
The price-to-earnings (P/E) ratio for Pharming Group NV (PHARM) is 55.90 (data as of 2026-05-24).
Does Pharming Group NV pay a dividend?
Dividend yield is not available in the current snapshot for Pharming Group NV (PHARM). Check the MyAverix Finance app for the latest dividend data.
What sector is Pharming Group NV in?
Pharming Group NV (PHARM) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PHARM listed on?
PHARM is listed on AS.
What is Pharming Group NV's net margin?
Pharming Group NV (PHARM) reports a net margin of 3.3% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.